Naltrexone And Bupropion
Pharmacological and Behavioral Treatment After Bariatric Surgery
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 84
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| BWL + NB medication | n/r | n/r | n/r | n/r |
| BWL + Placebo | n/r | n/r | n/r | n/r |
| NB medication | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- BWL + NB medication: endpoint not reported
- BWL + Placebo: endpoint not reported
- NB medication: endpoint not reported
- Placebo: endpoint not reported